» Articles » PMID: 32257440

Bone Mass Loss and Sarcopenia in Ecuadorian Patients

Overview
Journal J Aging Res
Publisher Wiley
Specialty Geriatrics
Date 2020 Apr 8
PMID 32257440
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the association between osteoporosis and sarcopenia and determine the prevalence of osteosarcopenia in patients who attended a rheumatology center in Ecuador.

Methods: A cross-sectional study was conducted in a population of patients who had a densitometric study. The diagnosis of sarcopenia was determined by the DXA standard gold test, screening, and conventional methods (bioimpedance, anthropometric measurements, SARC-F, muscle function, and gait test).

Results: A total of 92 patients were studied. The median age was 66 ± 10, 90% females. Using the criteria of SMI, 65% had sarcopenia of which 9% had only sarcopenia and 56% had osteosarcopenia; 22% had only osteopenia/osteoporosis; and 13% none of these conditions. The prevalence of sarcopenia according to handgrip strength was 60%, gait speed 45%, and SARC-F score 40%. The prevalence of osteosarcopenia according to handgrip strength was 51%, gait speed 34%, and SARC-F score 32%. Osteoporosis was associated with a higher prevalence of sarcopenia using the criteria of SMI since 40% had sarcopenia in the normal DXA group, 64% in the osteopenia group, and 76% in the osteoporosis group (=0.017). Of the women, 69% had sarcopenia compared to 33% of the men (=0.034). The BMI was lower in the group with sarcopenia (25.1 ± 4.1 kg/m) compared to the group without sarcopenia (29.4 ± 4.1 kg/m, < 0.001). Patients with osteosarcopenia and sarcopenia had lower BMI, handgrip strength, ASM, SMI, and total-body skeletal muscle mass than those with osteopenia/osteoporosis or normal patients.

Conclusion: 65% of the studied population had sarcopenia. It is clear that the prevalence of sarcopenia is higher in patients with greater loss of bone mass. Identifying pathways that affect both bone and muscle could facilitate the development of treatments that simultaneously improve osteoporosis and sarcopenia.

Citing Articles

Prevalence and risk factors of osteosarcopenia: a systematic review and meta-analysis.

Huang T, Li C, Chen F, Xie D, Yang C, Chen Y BMC Geriatr. 2023; 23(1):369.

PMID: 37322416 PMC: 10273636. DOI: 10.1186/s12877-023-04085-9.


Use of artificial neural networks in the prognosis of musculoskeletal diseases-a scoping review.

Qiu F, Li J, Zhang R, Legerlotz K BMC Musculoskelet Disord. 2023; 24(1):86.

PMID: 36726111 PMC: 9890715. DOI: 10.1186/s12891-023-06195-2.


Prevalence and associated factors of sarcopenia in community-dwelling older adults at risk of malnutrition.

Chew S, Tey S, Yalawar M, Liu Z, Baggs G, How C BMC Geriatr. 2022; 22(1):997.

PMID: 36564733 PMC: 9789557. DOI: 10.1186/s12877-022-03704-1.


Explainable Artificial Intelligence and Wearable Sensor-Based Gait Analysis to Identify Patients with Osteopenia and Sarcopenia in Daily Life.

Kim J, Bae M, Lee K, Kim J, Hong S Biosensors (Basel). 2022; 12(3).

PMID: 35323437 PMC: 8946270. DOI: 10.3390/bios12030167.


Associations between Physical Function, Bone Density, Muscle Mass and Muscle Morphology in Older Men with Sarcopenia: A Pilot Study.

Mastaviciute A, Kilaite J, Petroska D, Laurinavicius A, Tamulaitiene M, Alekna V Medicina (Kaunas). 2021; 57(2).

PMID: 33572100 PMC: 7915644. DOI: 10.3390/medicina57020156.

References
1.
Yoo J, Ha Y, Kwon H, Lee Y, Koo K, Yoo M . High Prevalence of Sarcopenia in Korean Patients after Hip Fracture: a Case-Control Study. J Korean Med Sci. 2016; 31(9):1479-84. PMC: 4974192. DOI: 10.3346/jkms.2016.31.9.1479. View

2.
Yang M, Hu X, Xie L, Zhang L, Zhou J, Lin J . Comparing Mini Sarcopenia Risk Assessment With SARC-F for Screening Sarcopenia in Community-Dwelling Older Adults. J Am Med Dir Assoc. 2018; 20(1):53-57. DOI: 10.1016/j.jamda.2018.04.012. View

3.
da Silva A, Matos A, Ribeiro R, Gil A, Valente A, Bicho M . Sarcopenia and osteoporosis in Portuguese centenarians. Eur J Clin Nutr. 2016; 71(1):56-63. DOI: 10.1038/ejcn.2016.174. View

4.
Lera L, Albala C, Sanchez H, Angel B, Hormazabal M, Marquez C . Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria. J Frailty Aging. 2017; 6(1):12-17. DOI: 10.14283/jfa.2016.117. View

5.
Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F . Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. PMC: 2886201. DOI: 10.1093/ageing/afq034. View